Cardiac transplant
Cardiac Transplant or Heart Transplant is a surgical procedure performed on patients with end-stage heart failure or severe coronary artery disease. The procedure involves the replacement of the patient's diseased heart with a healthy heart from a deceased donor.
History[edit | edit source]
The first human heart transplant was performed by Christiaan Barnard in 1967 at Groote Schuur Hospital in Cape Town, South Africa. The patient, Louis Washkansky, survived for 18 days after the procedure. The first successful long-term survival after a heart transplant was achieved in 1968 by a team led by Norman Shumway at Stanford University.
Indications[edit | edit source]
Cardiac transplant is considered for patients with end-stage heart failure who have not responded to conventional medical or surgical treatments. Conditions that may lead to the need for a heart transplant include dilated cardiomyopathy, ischemic cardiomyopathy, congenital heart disease, and valvular heart disease.
Procedure[edit | edit source]
The procedure begins with the removal of the donor's heart, which is preserved in a cold solution to prolong its viability. The recipient's diseased heart is then removed, leaving a portion of the atria, the upper chambers of the heart. The donor heart is then sewn into place.
Post-Transplant Care[edit | edit source]
After the procedure, patients are typically monitored in the intensive care unit for several days. Immunosuppressive drugs are administered to prevent the body from rejecting the new heart. Regular follow-up appointments and heart biopsies are also part of the post-transplant care to monitor for signs of rejection.
Risks and Complications[edit | edit source]
Complications of cardiac transplant include infection, bleeding, and organ rejection. Long-term complications may include coronary artery disease, kidney failure, and malignancies due to immunosuppressive therapy.
Prognosis[edit | edit source]
The prognosis after a cardiac transplant varies, with a median survival rate of approximately 11 years. Factors influencing survival include age, overall health, and response to immunosuppressive therapy.
See Also[edit | edit source]
This article is a cardiovascular system stub. You can help WikiMD by expanding it!
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
